JR-141

· JCR Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for JR-141, covering 2022-11-14 to 2026-06-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT) [Phase 3]